Trier Clayton 4
4 · U S PHYSICAL THERAPY INC /NV · Filed Dec 5, 2022
Insider Transaction Report
Form 4
Trier Clayton
Director
Transactions
- Sale
Common Stock
2022-12-01$88.68/sh−800$70,944→ 9,780 total - Sale
Common Stock
2022-12-01$88.09/sh−1,540$135,659→ 8,240 total - Sale
Common Stock
2022-12-02$89.57/sh−400$35,828→ 7,840 total
Footnotes (4)
- [F1]The price reported is a weighted average price $88.68. The shares were sold in multiple transactions at prices ranging from $88.45 to $88.95 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F2]800 of these shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares on January 1, 2023 and April 1, 2023, if he is a director of the Company on those dates.
- [F3]The price reported is a weighted average price $88.09. The shares were sold in multiple transactions at prices ranging from $87.80 to $88.41 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F4]The price reported is a weighted average price $89.57. The shares were sold in multiple transactions at prices ranging from $89.50 to $89.60 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.